Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Schering Will Audit Compliance With Anti-Bribery Law Under SEC Settlement

Executive Summary

Schering-Plough will retain an independent consultant to review its compliance with the Foreign Corrupt Practices Act as part of a $500,000 settlement with the Securities & Exchange Commission

You may also be interested in...



SEC, DoJ Beef Up Investigation of Corporate Bribery & Corruption Overseas

Pharma companies have been battered by government and congressional investigations of their domestic marketing practices. They now face increased scrutiny on another front as the Department of Justice and the Securities and Exchange Commission are stepping up their investigation of corporate corruption and bribery abroad

SEC, DoJ Beef Up Investigation of Corporate Bribery & Corruption Overseas

Pharma companies have been battered by government and congressional investigations of their domestic marketing practices. They now face increased scrutiny on another front as the Department of Justice and the Securities and Exchange Commission are stepping up their investigation of corporate corruption and bribery abroad

Pharma CEO Mission Is Defined By Complexity, Products And Trust – Hassan

The explosion in pharmaceutical industry partnerships is one reason that managing "complexity" is a critical core competency for industry leaders, Schering-Plough CEO Fred Hassan told the Pharma, Biotech & Device Colloquium in Princeton, N.J. June 7

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel